Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
4.000
-0.010 (-0.25%)
At close: Apr 28, 2026, 4:00 PM EDT
3.840
-0.160 (-4.00%)
After-hours: Apr 28, 2026, 6:30 PM EDT
Cellectis Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Cellectis stock have an average target of 8.33, with a low estimate of 8.00 and a high estimate of 9.00. The average target predicts an increase of 108.25% from the current stock price of 4.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Cellectis stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens | Citizens | Buy Reiterates $8 | Buy | Reiterates | $8 | +100.00% | Apr 14, 2026 |
| Clear Street | Clear Street | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +125.00% | Dec 23, 2025 |
| Barclays | Barclays | Buy Maintains $4 → $8 | Buy | Maintains | $4 → $8 | +100.00% | Oct 17, 2025 |
| Barclays | Barclays | Buy Maintains $5 → $4 | Buy | Maintains | $5 → $4 | n/a | May 13, 2025 |
| Barclays | Barclays | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +25.00% | Nov 5, 2024 |
Financial Forecast
Revenue This Year
58.42M
from 79.59M
Decreased by -26.60%
Revenue Next Year
58.99M
from 58.42M
Increased by 0.98%
EPS This Year
-1.10
from -0.67
EPS Next Year
-1.39
from -1.10
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 66.7M | 107.2M | |||||
| Avg | 58.4M | 59.0M | |||||
| Low | 39.2M | 24.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | -16.2% | 83.5% | |||||
| Avg | -26.6% | 1.0% | |||||
| Low | -50.7% | -58.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.86 | -1.01 | |
| Avg | -1.10 | -1.39 | |
| Low | -1.59 | -1.79 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.